Skip to main content
Top
Published in: International Journal of Hematology 4/2017

01-04-2017 | Case Report

Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis

Authors: Yongwei Wang, Yali Du, Gang Liu, Shanshan Guo, Bo Hou, Xianyong Jiang, Bing Han, Yanzhong Chang, Guangjun Nie

Published in: International Journal of Hematology | Issue 4/2017

Login to get access

Abstract

Hereditary hemochromatosis (HH) is a group of inherited iron-overload disorders associated with pathogenic defects in the genes encoding hemochromatosis (HFE), hemojuvelin (HJV/HFE2), hepcidin (HAMP), transferrin receptor 2 (TfR2), and ferroportin (FPN1/SLC40A1) proteins, and the clinical features are well described. However, there have been only a few detailed reports of HH in Chinese populations. Thus, there is insufficient patient information for population-based analyses in Chinese populations or comparative studies among different ethical groups. In the current work, we describe eight Chinese cases of hereditary hemochromatosis. Gene sequencing results revealed eight mutations (five novel mutations) in HFE, HFE2, TfR2, and SLC40A1 genes in these Chinese HH patients. In addition, we used Polymorphism Phenotyping v2 (Polyphen), Sorting Intolerant From Tolerant (SIFT), and a sequence alignment program to predict the molecular consequences of missense mutations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pietrangelo A. Medical progress—hereditary hemochromatosis—a new look at an old disease. N Engl J Med. 2004;350:2383–97.CrossRefPubMed Pietrangelo A. Medical progress—hereditary hemochromatosis—a new look at an old disease. N Engl J Med. 2004;350:2383–97.CrossRefPubMed
3.
go back to reference Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.CrossRefPubMed Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.CrossRefPubMed
4.
go back to reference Papanikolaou G, Samuels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77–82.CrossRefPubMed Papanikolaou G, Samuels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77–82.CrossRefPubMed
5.
go back to reference Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood. 2004;104:2176–7.CrossRefPubMed Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood. 2004;104:2176–7.CrossRefPubMed
6.
go back to reference Majore S, Ricerca BM, Radio FC, Binni F, Cosentino I, Gallusi G, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis. 2013;50:31–2.CrossRefPubMed Majore S, Ricerca BM, Radio FC, Binni F, Cosentino I, Gallusi G, et al. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction? Blood Cells Mol Dis. 2013;50:31–2.CrossRefPubMed
7.
go back to reference Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis. 2001;27:285–9.CrossRefPubMed Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis. 2001;27:285–9.CrossRefPubMed
8.
go back to reference McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309.CrossRefPubMed McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309.CrossRefPubMed
9.
go back to reference Liu WD, Shimomura S, Imanishi H, Iwamoto Y, Ikeda N, Saito M, et al. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern Med. 2005;44:285–9.CrossRefPubMed Liu WD, Shimomura S, Imanishi H, Iwamoto Y, Ikeda N, Saito M, et al. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern Med. 2005;44:285–9.CrossRefPubMed
Metadata
Title
Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis
Authors
Yongwei Wang
Yali Du
Gang Liu
Shanshan Guo
Bo Hou
Xianyong Jiang
Bing Han
Yanzhong Chang
Guangjun Nie
Publication date
01-04-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2150-8

Other articles of this Issue 4/2017

International Journal of Hematology 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine